United States Pharmaceuticals

Harmony Biosciences Holdings Inc (HRMY)

Track

Harmony Biosciences Holdings Inc. experienced nine insider trading transactions over the past ninety days, totaling approximately $32.45 million in proposed sales. These divestments involved a director and a former officer. This activity follows a recent earnings report where the company exceeded expectations by 31.96 percent, coinciding with a 27.3 percent stock price increase.
Ticker: HRMY Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Harmony Biosciences Holdings Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Proposed sale 7 Aug 2026
Value US$92,791.70 | Price 317.08 | Shares 41,252
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-07 2026-08-07 PrS Proposed sale
0.7
VALOR IV PHARMA HOLDINGS LLC

Director

Non-Executive Director
41,252
317.08
US$92,792 		41,252 317.08 US$92,792
2026-07-02 2026-07-02 PrS Proposed sale
SANDIP KAPADIA

Former Officer

Officer
82,476
265.87
US$1,045,602 		82,476 265.87 US$1,045,602
2026-06-30 2026-06-30 PrS Proposed sale
SANDIP KAPADIA

Former Officer

Officer
52,240
481.31
US$3,159,487 		52,240 481.31 US$3,159,487
2026-06-26 2026-06-26 PrS Proposed sale
SANDIP KAPADIA

Former Officer

Officer
45,594
35.24
US$1,606,824 		45,594 35.24 US$1,606,824
2026-06-24 2026-06-24 PrS Proposed sale
SANDIP KAPADIA

Former Officer

Officer
4,406
35.02
US$154,302 		4,406 35.02 US$154,302
2026-06-24 2026-06-24 PrS Proposed sale
SANDIP KAPADIA

Former Officer

Officer
4,406
35.02
US$154,302 		4,406 35.02 US$154,302
2026-06-09 2026-06-09 PrS Proposed sale
SANDIP KAPADIA

Former Officer

Officer
27,960
33.74
US$943,264 		27,960 33.74 US$943,264
2026-06-05 2026-06-05 PrS Proposed sale
SANDIP KAPADIA

Former Officer

Officer
2,101
33.08
US$69,504 		2,101 33.08 US$69,504
2026-06-04 2026-06-04 PrS Proposed sale
SANDIP KAPADIA

Former Officer

Officer
7,064
33.02
US$233,232 		7,064 33.02 US$233,232
2026-05-08 2026-05-08 PrS Proposed sale
SANDIP KAPADIA

Former Officer

Officer
45,481
31.51
US$1,433,056 		45,481 31.51 US$1,433,056
2026-01-28 2026-01-26 PlS Planned sale
Kapadia Sandip

CHIEF FINANCIAL OFFICER

Officer
3,746 -13.3%
37.15
US$139,171 		3,746 -13.3% 37.15 US$139,171
2026-01-26 2026-01-26 PrS Proposed sale
SANDIP KAPADIA

Officer

Officer
3,746
36.82
US$137,928 		3,746 36.82 US$137,928
2026-01-20 2026-01-15 PlS Planned sale
Kapadia Sandip

CHIEF FINANCIAL OFFICER

Officer
20,961 -100.0%
35.92
US$752,833 		20,961 -100.0% 35.92 US$752,833
2026-01-15 2026-01-15 PrS Proposed sale
SANDIP KAPADIA

Officer

Officer
20,961
36.04
US$755,434 		20,961 36.04 US$755,434
2025-12-17 2025-12-12 PlS Planned sale
Dayno Jeffrey M.

PRESIDENT, CEO

Executive Director
5,933 -100.0%
40.11
US$237,957 		5,933 -100.0% 40.11 US$237,957
2025-12-17 2025-12-12 PlS Planned sale
Dayno Jeffrey M.

PRESIDENT, CEO

Executive Director
20,000 -100.0%
40.11
US$802,146 		20,000 -100.0% 40.11 US$802,146
2025-12-12 2025-12-12 PrS Proposed sale
JEFFREY M DAYNO

Director; Officer

Executive Director
25,933
39.59
US$1,026,687 		25,933 39.59 US$1,026,687
2025-12-09 2025-12-05 PlS Planned sale
Kapadia Sandip

CHIEF FINANCIAL OFFICER

Officer
20,000 -100.0%
39.54
US$790,896 		20,000 -100.0% 39.54 US$790,896
2025-12-05 2025-12-05 PrS Proposed sale
SANDIP KAPADIA

Officer

Officer
20,000
38.25
US$765,000 		20,000 38.25 US$765,000
2025-11-25 2025-11-21 PlS Planned sale
Kapadia Sandip

CHIEF FINANCIAL OFFICER

Officer
3,427 -100.0%
35.00
US$119,945 		3,427 -100.0% 35.00 US$119,945
2025-11-21 2025-11-21 PrS Proposed sale
SANDIP KAPADIA

Officer

Officer
3,427
33.39
US$114,428 		3,427 33.39 US$114,428
2025-08-19 2025-08-15 PlS Planned sale
Kapadia Sandip

CHIEF FINANCIAL OFFICER

Officer
21,573 -100.0%
36.50
US$787,378 		21,573 -100.0% 36.50 US$787,378
2025-08-15 2025-08-15 PrS Proposed sale
SANDIP KAPADIA

Officer

Officer
21,573
36.51
US$787,630 		21,573 36.51 US$787,630
2025-06-10 2025-06-10 PrS Proposed sale
JEFFREY G DIERKS

Former Officer

Officer
5,615
35.98
US$202,009 		5,615 35.98 US$202,009
2025-05-19 2025-05-19 PrS Proposed sale
JEFFREY G DIERKS

Former Officer

Officer
9,844
35.56
US$350,083 		9,844 35.56 US$350,083
2025-05-16 2025-05-16 PrS Proposed sale
JEFFREY G DIERKS

Former Officer

Officer
2,292
35.09
US$80,427 		2,292 35.09 US$80,427
2025-05-12 2025-05-12 PrS Proposed sale
JEFFREY G DIERKS

Former Officer

Officer
5,000
35.19
US$175,955 		5,000 35.19 US$175,955
2025-05-09 2025-05-09 PrS Proposed sale
JEFFREY G DIERKS

Former Officer

Officer
4,972
34.22
US$170,119 		4,972 34.22 US$170,119
2025-05-08 2025-05-08 PrS Proposed sale
JEFFREY G DIERKS

Former Officer

Officer
13,000
33.76
US$438,873 		13,000 33.76 US$438,873
2025-05-07 2025-05-07 PrS Proposed sale
JEFFREY G DIERKS

Former Officer

Officer
31,000
32.47
US$1,006,645 		31,000 32.47 US$1,006,645
2025-04-03 2025-04-01 PlS Planned sale
Kapadia Sandip

CHIEF FINANCIAL OFFICER

Officer
740 -100.0%
33.12
US$24,505 		740 -100.0% 33.12 US$24,505
2025-04-03 2025-04-01 PlS Planned sale
Kapadia Sandip

CHIEF FINANCIAL OFFICER

Officer
6,247 -89.4%
32.48
US$202,881 		6,247 -89.4% 32.48 US$202,881
2025-04-01 2025-04-01 PrS Proposed sale
SANDIP KAPADIA

Officer

Officer
6,986
33.19
US$231,865 		6,986 33.19 US$231,865
2025-03-05 2025-03-03 PlS Planned sale
Dierks Jeffrey

CHIEF COMMERCIAL OFFICER

Officer
500 -100.0%
33.23
US$16,615 		500 -100.0% 33.23 US$16,615
2025-03-05 2025-03-03 PlS Planned sale
Dierks Jeffrey

CHIEF COMMERCIAL OFFICER

Officer
4,369 -89.7%
32.61
US$142,474 		4,369 -89.7% 32.61 US$142,474
2025-03-03 2025-03-03 PrS Proposed sale
JEFFREY G DIERKS

Officer

Officer
4,869
33.85
US$164,816 		4,869 33.85 US$164,816
2025-01-28 2025-01-27 PlS Planned sale
Kapadia Sandip

CHIEF FINANCIAL OFFICER

Officer
1,775 -100.0%
38.05
US$67,547 		1,775 -100.0% 38.05 US$67,547
2025-01-28 2025-01-27 PlS Planned sale
Dierks Jeffrey

CHIEF COMMERCIAL OFFICER

Officer
1,629 -100.0%
38.02
US$61,941 		1,629 -100.0% 38.02 US$61,941
2025-01-27 2025-01-27 PrS Proposed sale
JEFFREY G DIERKS

Officer

Officer
1,629
38.01
US$61,918 		1,629 38.01 US$61,918
2025-01-27 2025-01-27 PrS Proposed sale
SANDIP KAPADIA

Officer

Officer
1,775
38.01
US$67,468 		1,775 38.01 US$67,468
2025-01-28 2025-01-24 PlS Planned sale
Dierks Jeffrey

CHIEF COMMERCIAL OFFICER

Officer
5,125 -100.0%
37.87
US$194,103 		5,125 -100.0% 37.87 US$194,103
2025-01-28 2025-01-24 PlS Planned sale
Dierks Jeffrey

CHIEF COMMERCIAL OFFICER

Officer
8,000 -61.0%
36.94
US$295,531 		8,000 -61.0% 36.94 US$295,531
2025-01-24 2025-01-24 PrS Proposed sale
JEFFREY G DIERKS

Officer

Officer
13,125
38.01
US$498,881 		13,125 38.01 US$498,881
2025-01-23 2025-01-21 PlS Planned sale
Dayno Jeffrey M.

PRESIDENT, CEO

Executive Director
19,293 -100.0%
40.13
US$774,245 		19,293 -100.0% 40.13 US$774,245
2025-01-23 2025-01-21 PlS Planned sale
Kapadia Sandip

CHIEF FINANCIAL OFFICER

Officer
25,000 -100.0%
40.18
US$1,004,598 		25,000 -100.0% 40.18 US$1,004,598
2025-01-21 2025-01-21 PrS Proposed sale
SANDIP KAPADIA

Officer

Officer
25,000
39.05
US$976,250 		25,000 39.05 US$976,250
2025-01-21 2025-01-21 PrS Proposed sale
JEFFREY M DAYNO

Director; Officer

Executive Director
19,293
39.05
US$753,392 		19,293 39.05 US$753,392
2025-01-21 2025-01-21 PrS Proposed sale
JEFFREY G DIERKS

Officer

Officer
1,123
39.05
US$43,853 		1,123 39.05 US$43,853
2025-01-21 2025-01-21 PlS Planned sale
Dierks Jeffrey

CHIEF COMMERCIAL OFFICER

Officer
1,123 -100.0%
40.00
US$44,920 		1,123 -100.0% 40.00 US$44,920
2025-01-21 2025-01-16 PlS Planned sale
Dierks Jeffrey

CHIEF COMMERCIAL OFFICER

Officer
29,475 -100.0%
37.41
US$1,102,795 		29,475 -100.0% 37.41 US$1,102,795
2025-01-16 2025-01-15 PlS Planned sale
Dierks Jeffrey

CHIEF COMMERCIAL OFFICER

Officer
10,507 -100.0%
37.01
US$388,841 		10,507 -100.0% 37.01 US$388,841
2025-01-15 2025-01-13 PlS Planned sale
Dierks Jeffrey

CHIEF COMMERCIAL OFFICER

Officer
7,180 -100.0%
37.04
US$265,946 		7,180 -100.0% 37.04 US$265,946
2025-01-13 2025-01-13 PrS Proposed sale
JEFFREY G DIERKS

Officer

Officer
47,162
33.86
US$1,596,905 		47,162 33.86 US$1,596,905
2024-11-05 2024-11-05 S Sale
0.7
Valor IV Pharma Holdings, LLC
Large shareholder
600,000 -8.3%
30.30
US$18,181,500 		600,000 -8.3% 30.30 US$18,181,500
2024-11-05 2024-11-05 S Sale
0.7
Marshman Fund Trust II
Large shareholder
600,000 -9.0%
30.30
US$18,181,500 		600,000 -9.0% 30.30 US$18,181,500
2024-11-05 2024-11-01 S Sale
0.7
Valor IV Pharma Holdings, LLC
Large shareholder
4,000,000 -35.7%
30.30
US$121,210,000 		4,000,000 -35.7% 30.30 US$121,210,000
2024-11-05 2024-11-01 S Sale
0.7
Marshman Fund Trust II
Large shareholder
4,000,000 -37.6%
30.30
US$121,210,000 		4,000,000 -37.6% 30.30 US$121,210,000
2024-10-31 2024-10-29 PlS Planned sale
Dierks Jeffrey

CHIEF COMMERCIAL OFFICER

Officer
21,496 -100.0%
40.47
US$870,018 		21,496 -100.0% 40.47 US$870,018
2024-10-29 2024-10-29 PrS Proposed sale
JEFFREY G DIERKS

Officer

Officer
21,496
35.75
US$768,482 		21,496 35.75 US$768,482
2024-10-07 2024-10-03 PlS Planned sale
Dierks Jeffrey

CHIEF COMMERCIAL OFFICER

Officer
705 -100.0%
35.62
US$25,111 		705 -100.0% 35.62 US$25,111
2024-10-07 2024-10-03 PlS Planned sale
Dierks Jeffrey

CHIEF COMMERCIAL OFFICER

Officer
35,652 -98.1%
35.05
US$1,249,435 		35,652 -98.1% 35.05 US$1,249,435
2024-10-03 2024-10-03 PrS Proposed sale
JEFFREY G DIERKS

Officer

Officer
14,961
35.57
US$532,163 		14,961 35.57 US$532,163
2024-10-02 2024-10-01 PlS Planned sale
Dierks Jeffrey

CHIEF COMMERCIAL OFFICER

Officer
400 -100.0%
40.19
US$16,077 		400 -100.0% 40.19 US$16,077
2024-10-01 2024-10-01 PrS Proposed sale
JEFFREY G DIERKS

Officer

Officer
21,796
40.00
US$871,840 		21,796 40.00 US$871,840
2024-10-01 2024-09-30 PlS Planned sale
Dierks Jeffrey

CHIEF COMMERCIAL OFFICER

Officer
35,846 -100.0%
40.03
US$1,434,951 		35,846 -100.0% 40.03 US$1,434,951
2024-09-30 2024-09-27 PlS Planned sale
Dierks Jeffrey

CHIEF COMMERCIAL OFFICER

Officer
200 -100.0%
40.05
US$8,009 		200 -100.0% 40.05 US$8,009
2024-09-27 2024-09-27 PrS Proposed sale
JEFFREY G DIERKS

Officer

Officer
28,971
39.79
US$1,152,756 		28,971 39.79 US$1,152,756
2024-03-18 2024-03-15 PlS Planned sale
Dierks Jeffrey

CHIEF COMMERCIAL OFFICER

Officer
11,979 -100.0%
32.00
US$383,328 		11,979 -100.0% 32.00 US$383,328
2024-03-15 2024-03-15 PrS Proposed sale
JEFFREY G DIERKS

Officer

Officer
11,979
31.36
US$375,661 		11,979 31.36 US$375,661
2024-03-11 2024-03-08 PlS Planned sale
Dierks Jeffrey

CHIEF COMMERCIAL OFFICER

Officer
194 -100.0%
32.00
US$6,208 		194 -100.0% 32.00 US$6,208
2024-03-08 2024-03-08 PrS Proposed sale
JEFFREY G DIERKS

Officer

Officer
194
31.04
US$6,022 		194 31.04 US$6,022
2022-12-16 2022-12-14 PlS Planned sale
2.3
Nielsen Jack
Non-Executive Director
2,834 -0.1%
59.96
US$169,927 		2,834 -0.1% 59.96 US$169,927
2022-12-14 2022-12-14 S Sale
3.3
Wicki Andreas
Non-Executive Director
130 -0.0%
60.00
US$7,800 		130 -0.0% 60.00 US$7,800
2022-12-14 2022-12-13 S Sale
3.3
Wicki Andreas
Non-Executive Director
6,320 -0.3%
60.13
US$380,022 		6,320 -0.3% 60.13 US$380,022
2022-12-14 2022-12-12 S Sale
3.3
Wicki Andreas
Non-Executive Director
22,391 -1.0%
60.36
US$1,351,521 		22,391 -1.0% 60.36 US$1,351,521
Explore more

More insider trading research around Harmony Biosciences Holdings Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America